Questions pile up for Novartis as senators call on FDA to take action

Questions pile up for Novartis as senators call on FDA to take action

Source: 
Endpoints
snippet: 

Why wait three months to tell the FDA about manipulated data? Why wait two months between documenting an initial issue and opening a nonconformance report (NCR)? And how harshly will the FDA act?